loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 212819 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CILASTATIN SODIUM; IMIPENEM; RELEBACTAM (1)

filter

01 MSD MERCK CO (1)

filter

01 POWDER;INTRAVENOUS (1)

filter

01 EQ 500MG BASE/VIAL;500MG/VIAL;250MG/VIAL (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;INTRAVENOUS
EQ 500MG BASE/VIAL;500...
RECARBRIO
USA
212819
2019-07-16
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 212819

Looking for CTD TGA MCC DOSSIER APPLICATION 212819 1

19

MSD INTL GMBH, based in Singapore, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is CILASTATIN SODIUM; IMIPENEM; RELEBACTAM, with a corresponding application number 212819 and regulatory information .

proudly manufactured in the

approval since 2019-07-16

MSD INTL GMBH's RECARBRIO POWDER;INTRAVENOUS, medication with EQ 500MG BASE/VIAL;500MG/VIAL;250MG/VIAL of CILASTATIN SODIUM; IMIPENEM; RELEBACTAM.

Post Enquiry
POST ENQUIRY